SCHEMBL14814136

SCHEMBL14814136

Cc1cc(O)ccc1-c1ccc2c(C)n[nH]c2n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 1/20 0.44
MEN1 O00255 1/20 0.43
ALDH1A1 P00352 1/20 0.43
MAPT P10636 1/20 0.43
ALOX12 P18054 1/20 0.43
MAPK10 P53779 1/20 0.43
KMT2A Q03164 1/20 0.43
ATM Q13315 1/20 0.43
ESR2 Q92731 9/20 0.41
ESR1 P03372 9/20 0.41
CDK2 P24941 3/20 0.39
CHEK1 O14757 1/20 0.39
CDK4 P11802 1/20 0.39
CCNA2 P20248 1/20 0.39
CCND1 P24385 1/20 0.39
CCND3 P30281 1/20 0.39
KDR P35968 1/20 0.39
GSK3A P49840 2/20 0.36
GSK3B P49841 2/20 0.36
MYLK Q15746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14814114 0.86 ESR1 (0.40) FGFR1ESR2ESR1CDK2GSK3A
SCHEMBL14813778 0.74 ALPL (0.40) FGFR1MEN1ALDH1A1MAPTALOX12
SCHEMBL21188573 0.71 LRRK2 (0.32) ESR2ESR1GSK3AGSK3B
SCHEMBL14813604 0.69 ALK (0.46) FGFR1ESR2ESR1CDK2GSK3A
SCHEMBL12035368 0.69 CDK4 (0.47) FGFR1MEN1ALDH1A1KMT2AESR2
SCHEMBL17162809 0.68 ESR2 (0.43) FGFR1MEN1ALDH1A1MAPTALOX12
SCHEMBL176952 0.68 PDPK1 (0.59) FGFR1MEN1ALDH1A1MAPTKMT2A
SCHEMBL16385229 0.67 MEN1 (0.54) FGFR1MEN1ALDH1A1MAPTALOX12
SCHEMBL7926347 0.67 ADORA1 (0.48) KMT2AGAA
SCHEMBL19479333 0.67 HSP90AA1 (0.47) FGFR1MEN1ALDH1A1MAPTALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130085128-A1 6-(4-Hydroxy-phenyl)-3-alkyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors SANOFI (FR) 2013-04-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130085128-A1 6-(4-Hydroxy-phenyl)-3-alkyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors MAP3K1, MAP3K6, MAP4K2 FGFR1 194/4885MEN1 4777/4885ALDH1A1 1088/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.